1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Shape
3.3. Snippet by Placement
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing prevalence of breast cancer worldwide is expected to drive market growth.
4.1.1.2. Growing Awareness about breast reconstruction treatment
4.1.2. Restraints
4.1.2.1. The high cost of breast surgical procedures is expected to hamper the market growth
4.1.3. Opportunity
4.1.3.1. The introduction of 3D-printed implants may present significant advantages market expansion opportunities
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Before COVID-19 Scenario
6.1.2. Present COVID-19 Scenario
6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Impact Analysis
9. By Product Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.1.2. Market Attractiveness Index, By Product Type
9.2. Implants
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Tissue Expander
9.4. Acellular Dermal Matrix
10. By Shape
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
10.1.2. Market Attractiveness Index, By Shape
10.2. Round Shape
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Anatomical Shape
11. By Placement
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
11.1.2. Market Attractiveness Index, By Placement
11.2. Dual Plane Insertion
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Subglandular Insertion
11.4. Submuscular Insertion
12. By End User
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.1.2. Market Attractiveness Index, By End User
12.2. Hospitals
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Ambulatory Surgical Centers
12.4. Others
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. The U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. The U.K.
13.3.7.3. France
13.3.7.4. Italy
13.3.7.5. Russia
13.3.7.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. Brazil
13.4.7.2. Argentina
13.4.7.3. Rest of South America
13.5. Asia-Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. China
13.5.7.2. India
13.5.7.3. Japan
13.5.7.4. Australia
13.5.7.5. Rest of Asia-Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Market Share Analysis
14.3. Mergers and Acquisitions Analysis
15. Company Profiles
15.1. Allergan Plc
15.1.1. Company Overview
15.1.2. Product Type Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. Sientra, Inc
15.3. IDEAL IMPLANT INCORPORATED
15.4. Johnson & Johnson
15.5. Establishment Labs S.A.
15.6. GC Aesthetics
15.7. Groupe Sebbin SAS
15.8. Ideal Implant Incorporated
15.9. Laboratoires Arion
15.10. Mentor Worldwide LLC.
16. Appendix
16.1. About Us and Services
16.2. Contact Us